Lifecore Biomedical Inc (LFCR)
4.92
-0.23
(-4.47%)
USD |
NASDAQ |
Jun 18, 15:57
Lifecore Biomedical Cash from Investing (Quarterly): -7.50M for May 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2023 | -8.158M |
| February 28, 2023 | 6.394M |
| November 30, 2022 | -3.253M |
| August 31, 2022 | 0.206M |
| May 31, 2022 | -18.80M |
| February 28, 2022 | 65.60M |
| November 30, 2021 | -5.097M |
| August 31, 2021 | 38.27M |
| May 31, 2021 | -13.81M |
| February 28, 2021 | -3.976M |
| November 30, 2020 | 5.246M |
| August 31, 2020 | 0.232M |
| May 31, 2020 | -4.566M |
| February 29, 2020 | -3.686M |
| November 30, 2019 | -5.97M |
| August 31, 2019 | -9.666M |
| May 31, 2019 | -4.424M |
| February 28, 2019 | -73.98M |
| November 30, 2018 | -3.953M |
| August 31, 2018 | -14.44M |
| May 31, 2018 | -12.84M |
| February 28, 2018 | -11.28M |
| November 30, 2017 | -4.594M |
| August 31, 2017 | -6.869M |
| May 31, 2017 | -16.01M |
| Date | Value |
|---|---|
| February 28, 2017 | -4.69M |
| November 30, 2016 | -2.602M |
| August 31, 2016 | -2.122M |
| May 31, 2016 | -13.54M |
| February 29, 2016 | -10.92M |
| November 30, 2015 | -12.57M |
| August 31, 2015 | -3.396M |
| May 31, 2015 | -7.16M |
| February 28, 2015 | -2.145M |
| November 30, 2014 | -10.04M |
| August 31, 2014 | -15.10M |
| May 31, 2014 | -4.694M |
| February 28, 2014 | -2.511M |
| November 30, 2013 | -2.039M |
| August 31, 2013 | -4.097M |
| May 31, 2013 | -2.094M |
| February 28, 2013 | -3.089M |
| November 30, 2012 | -2.454M |
| August 31, 2012 | -2.785M |
| May 31, 2012 | -43.21M |
| February 29, 2012 | -1.708M |
| November 30, 2011 | 6.395M |
| August 31, 2011 | -5.549M |
| May 31, 2011 | 1.823M |
| February 28, 2011 | -8.588M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-18.80M
Minimum
May 2022
65.60M
Maximum
Feb 2022
2.435M
Average
-3.831M
Median
Cash from Investing (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | -0.029M |
| SELLAS Life Sciences Group Inc | -- |
| ADMA Biologics Inc | -2.362M |
| Relmada Therapeutics Inc | 10.06M |
| Jaguar Health Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.29M |
| Cash from Financing (Quarterly) | 40.93M |